|
CTNNAL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.246200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.930200E-01 |
| Normal-vs-Stage2 |
1.444570E-01 |
| Normal-vs-Stage3 |
7.927600E-01 |
| Normal-vs-Stage4 |
6.345200E-01 |
| Stage1-vs-Stage2 |
8.638000E-02 |
| Stage1-vs-Stage3 |
7.417000E-01 |
| Stage1-vs-Stage4 |
6.191000E-01 |
| Stage2-vs-Stage3 |
1.627450E-01 |
| Stage2-vs-Stage4 |
3.045200E-01 |
| Stage3-vs-Stage4 |
8.079200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.500600E-01 |
| Normal-vs-AfricanAmerican |
5.548000E-01 |
| Normal-vs-Asian |
6.397000E-01 |
| Caucasian-vs-AfricanAmerican |
5.176400E-01 |
| Caucasian-vs-Asian |
6.366400E-01 |
| AfricanAmerican-vs-Asian |
3.873200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.794800E-01 |
| Normal-vs-Female |
8.175800E-01 |
| Male-vs-Female |
6.247000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.922600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.426200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.686000E-02 |
| Normal-vs-Age(81-100Yrs) |
2.685700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.345600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.356960E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.714000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.257200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.919900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.457200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.554600E-01 |
| Classical-VS-Follicular |
3.8187009110402E-11 |
| Classical-VS-Other |
8.635200E-01 |
| Classical-VS-Normal |
3.157800E-01 |
| Tall-VS-Follicular |
1.409900E-04 |
| Tall-VS-Other |
9.539600E-01 |
| Tall-VS-Normal |
7.204200E-01 |
| Follicular-VS-Other |
3.497800E-02 |
| Follicular-VS-Normal |
4.19930000000734E-05 |
| Other-VS-Normal |
7.965400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.490000E-01 |
| Normal-vs-N1 |
7.240800E-01 |
| N0-vs-N1 |
3.515600E-01 |
|
|
